Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toripalimab plus chemotherapy in locally advanced thymic epithelial tumor
NCT04667793Phase 2Unknown
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Jan 2021
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in thymic epithelial tumor (TET), sponsored by Shanghai Pulmonary Hospital. Status: unknown.
02
Drugs
toripalimab
03
Conditions
thymic epithelial tumor (TET)
Beyond the preview
Go deeper on NCT04667793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04667793.